BioCentury
ARTICLE | Clinical News

Lurbinectedin: Phase Ib data

June 22, 2015 7:00 AM UTC

Data from 21 evaluable patients with small cell lung cancer (SCLC) who failed 1 prior chemotherapy-containing regimen in an open-label, dose-escalation, dose-expansion, European Phase Ib trial showed ...